Gyre Therapeutics, Inc. Short-term Investments
Gyre Therapeutics, Inc. (GYRE) had Short-term Investments of $14.06 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-07
- 2026-06-30: Short-term Investments $14.06M.
- 2026-03-31: Short-term Investments $12.31M.
- 2025-12-31: Short-term Investments $15.36M.
- 2025-09-30: Short-term Investments $19.65M.
| Period end | Short-term Investments |
|---|---|
| 2026-06-30 | $14.06M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $12.31M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $15.36M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $19.65M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $17.87M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $14.85M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $14.86M 10-K · filed 2026-03-13 |
| 2024-09-30 | $9.23M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $9.00M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $7.57M 10-Q · filed 2024-05-13 |
| 2021-12-31 | $2.50M 10-K · filed 2023-03-30 |
| 2021-09-30 | $5.37M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $12.90M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $23.96M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $48.99M 10-K · filed 2022-03-31 |
| 2020-09-30 | $77.96M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $58.09M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $34.16M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $61.50M 10-K · filed 2021-03-04 |
| 2019-09-30 | $61.93M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $76.59M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $80.25M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $88.91M 10-K · filed 2020-02-20 |
| 2018-09-30 | $93.22M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $89.61M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $16.97M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $17.97M 10-K · filed 2019-03-08 |
| 2017-09-30 | $16.48M 10-Q · filed 2017-11-02 |
| 2016-12-31 | $6.80M 10-K · filed 2018-03-19 |
| 2016-09-30 | $10.21M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $12.62M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $7.09M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.40M 10-K · filed 2017-03-08 |
| 2015-09-30 | $13.66M 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |